North Carolina State University researchers have confirmed a previously undescribed species of Rickettsia in dogs and designated it Rickettsia finnyi, a finding that adds to the known diversity of tick‑associated pathogens affecting companion animals.

The organism was first observed in 2018 and initially reported in a 2020 case series involving three dogs. Subsequent laboratory work and broader testing by the university’s research team identified the organism in samples from a total of 19 dogs, with positive specimens collected from animals in the Southeast and the Midwest. Those additional detections expanded the geographic context of the discovery beyond the original cases.

The research began when veterinarians submitted blood samples that yielded molecular signals inconsistent with known Rickettsia species. “We first reported the novel species of Rickettsia in a 2020 case series involving three dogs,” said Barbara Qurollo, associate research professor at North Carolina State University, summarizing the early publication that flagged the organism. Qurollo and colleagues then pursued further laboratory characterization and comparative analysis to determine whether the organism warranted classification as a distinct species.

Rickettsia are obligate intracellular bacteria, meaning they grow inside host cells, a trait that complicates laboratory culture. “Rickettsia species are difficult to culture because these organisms grow inside of cells,” Qurollo said, noting one of the technical hurdles the team faced while confirming the organism as novel. The researchers relied on molecular sequencing and other laboratory techniques to differentiate R. finnyi from previously described spotted‑fever group organisms.

Clinically, infections with Rickettsial infections in dogs have produced signs in dogs that resemble Rocky Mountain spotted fever (RMSF), the best‑known spotted‑fever group illness in North America. Reported clinical features include fever, lethargy and manifestations consistent with vascular inflammation such as swelling, rash and pain. Rickettsial infections in dogs typically develop two to 14 days after tick transmission; the most common symptoms include fever (which can reach high temperatures), lethargy, loss of appetite and muscle or joint pain.

Public health and veterinary observers note that spotted‑fever group rickettsiae are already a significant concern for dogs across the United States, with seroprevalence studies showing widespread exposure to SFG organisms in the canine population. The discovery of R. finnyi therefore underscores the diversity of tick‑borne agents veterinarians may encounter and the importance of diagnostic vigilance.

The team named the species Rickettsia finnyi in honor of the first dog identified with the organism. “By naming it after an individual dog, we wanted to honor all companion dogs that have contributed to the discovery of new pathogens that could cause serious illness in both dogs and humans,” Qurollo said.

Coverage and further analysis of the discovery and its implications for canine tick‑borne disease surveillance have appeared in veterinary research outlets and canine health publications, including material from the AKC Canine Health Foundation. North Carolina State University led the research confirming Rickettsia finnyi and provided the clinical and laboratory details supporting the species designation.

For clinicians and owners, the finding highlights familiar diagnostic challenges: Rickettsial diseases often present with nonspecific signs that overlap with other febrile illnesses in dogs, and organisms that grow inside cells can be difficult to culture in routine laboratory settings. Dog owners and veterinarians routinely focus on tick prevention and diagnostic testing when faced with compatible clinical pictures; veterinary guidance commonly recommends year‑round tick control using veterinarian‑recommended products such as topical treatments (Advantix, Frontline Plus, Bravecto) or oral medications (Nexgard, Simparica) to reduce the risk of tick‑borne infections.

NC State’s confirmation of Rickettsia finnyi adds a new named organism to the spotted‑fever group and provides a foundation for further study of its distribution, tick vectors, clinical impact and potential cross‑reactivity with existing diagnostic tests. The university team’s sequencing and case documentation will inform veterinary laboratories and clinicians as they assess suspicious cases of tick‑associated illness in dogs.

Source

Original reporting: view the original article.